Page 5 - ஹரிஸ் பாரதியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹரிஸ் பாரதியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹரிஸ் பாரதியா Today - Breaking & Trending Today

Jubilant Pharmova Q4 PAT declines 19% to Rs 173 cr

Read more about Jubilant Pharmova Q4 PAT declines 19% to Rs 173 cr on Business Standard. On a consolidated basis, Jubilant Pharmova s net profit (from continuing operations) dropped 18.64% to Rs 172.68 crore on 0.71% rise in total revenue from operations to Rs 1,579.78 crore in Q4 March 2021 over Q4 March 2020. ....

Haris Bhartia , Shyams Bhartia , Contract Research , Development Services , Jubilant Life Sciences , Jubilant Pharmova , Jubilant Ingrevia , Capital Market , Finance Commission Of India , Harmaceuticals Nec , Jubilant Pharmova , Contract Manufacturing , Shyams Bhartia , Manufacturing Operations , Jubilant Life Sciences , O Chairman And Managing Director , Pari S , ஹரிஸ் பாரதியா , ஷியாம்கள் பாரதியா , ஒப்பந்த ஆராய்ச்சி , வளர்ச்சி சேவைகள் , மகிழ்ச்சி வாழ்க்கை அறிவியல் , மூலதனம் சந்தை , நிதி தரகு ஆஃப் இந்தியா ,

Jubilant Pharmova Limited posts Q4FY21 consolidated PAT of Rs. 213.90 crores

Jubilant Pharmova Limited posts Q4FY21 consolidated PAT of Rs. 213.90 crores
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Haris Bhartia , Shyams Bhartia , Contract Research , Development Services , Jubilant Pharmova , Pharmova Limited , Time Zone , Managing Director , Jubilant Ingrevia , Jubilant Pharmova Limited , ஹரிஸ் பாரதியா , ஷியாம்கள் பாரதியா , ஒப்பந்த ஆராய்ச்சி , வளர்ச்சி சேவைகள் , நேரம் ஸோந் , நிர்வகித்தல் இயக்குனர் ,

Jubilant Pharmova posts consolidated PAT of Rs 213.90 Cr in Q4FY21

Reports a total income of Rs 1586.47 crores ....

Haris Bhartia , Shyams Bhartia , Jubilant Pharmova , Jubilant Ingrevia , Shyams Bhartia , Haris Bhartia , ஹரிஸ் பாரதியா , ஷியாம்கள் பாரதியா ,

Investegate |DP Eurasia N.V Announcements | DP Eurasia N.V: Results of 2021 Extraordinary General Meeting

Investegate |DP Eurasia N.V Announcements | DP Eurasia N.V: Results of 2021 Extraordinary General Meeting
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United States , City Of , United Kingdom , Haris Bhartia , Shyams Bhartia , Selim Kender , David Adams , London Stock Exchange , Buchanan Financial Communications , Fides Food Systems Co , Jubilant Foodworks Limited , National Storage Mechanism , Domino Pizza , List Of The Financial Conduct Authority , For Immediate , General Meeting , Extraordinary General Meeting , Non Executive Director , Pratik Pota , Regulatory News , Chief Strategy Officer , Financial Communications , Giles Stewart , Official List , Financial Conduct Authority , ஒன்றுபட்டது மாநிலங்களில் ,

Jubilant Pharmova arm completes studies using novel oral formulation of Remdesivir

Jubilant Pharmova arm completes studies using novel oral formulation of Remdesivir
216
NEW DELHI, April 19, 2021 (BSS/PTI) – Jubilant Pharmova on Monday said its arm Jubilant Pharma has successfully completed studies using a novel oral formulation of Remdesivir used for treatment of COVID-19 against the available injectable formulation of the antiviral drug in India.
Jubilant Pharma has successfully completed “safety and pharmacokinetic/absorption studies in animals and healthy human volunteers in India using a novel oral formulation of Remdesivir against the commercially available injectable formulation of Remdesivir,” Jubilant Pharmova said in a filing to BSE.
Jubilant has sought authorisation for additional studies for this novel oral formulation from the Drug Controller General of India (DCGI), it added. ....

Haris Bhartia , Shyams Bhartia , Gilead Sciences Inc , Jubilant Pharmova , Jubilant Pharma , Drug Controller General , Pharmova Chairman Shyams Bhartia , Gilead Sciences , ஹரிஸ் பாரதியா , ஷியாம்கள் பாரதியா , கிலியட் அறிவியல் இன்க் , மகிழ்ச்சி பார்மா , மருந்து கட்டுப்படுத்தி ஜநரல் , கிலியட் அறிவியல் ,